GMPSOP

MARCH 3, 2024

Cross contamination in the pharmaceutical industry can be described as an accidental inclusion of product of another batch or unknown foreign material into a finished batch, which was not intended or not mentioned on the label. – According to the CDC , adverse drug events cause around 1.3 Additional documents included each month.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging Labelling Documentation 52

GMPSOP

MARCH 8, 2024

Out of trend results What is the origin of out of specification events? The court ruled that any individual OOS event should be investigated, and if a laboratory error cannot be identified, the batch will fail the test. – Please make sure that proper documentation is maintained and corrective action is undertaken.

Documentation 52

Documentation Dosage Pharmaceutical Manufacturing Packaging 52

European Pharmaceutical Review

JUNE 12, 2024

This randomised, open label-controlled multicentre clinical trial was conducted across 21 sites in Spain from 2021 to 2023. MBK-01 demonstrated a greater clinical benefit than fidaxomicin when used as the first choice for treatment of the current CDI episode event without any antibiotic treatment. percent compared to 61.54

Documentation 111

Documentation Labelling Hospitals 111

GMPSOP

APRIL 3, 2024

A pharmaceutical warehouse is responsible for receiving, storing, and releasing incoming goods (including labeling and packaging) and distributing finished products. Therefore, GMP rules ensure that materials are handled and stored properly and that appropriate documentation is maintained. Additional documents included each month.

Labelling 52

Labelling Packaging Documentation Inventory Control 52

Pharmacy Joe

MAY 1, 2024

Subscribe on iTunes , Android , or Stitcher The label of “penicillin allergic” usually sticks to a patient’s medical record forever. The documented allergy was severe in nature for 13% of patients, moderate for 43%, and unknown for 44%.

Inpatient 98

Inpatient Medical Records Documentation Labelling 98

pharmaphorum

DECEMBER 14, 2022

.” The experts reviewed data from the GALACTIC-HF trial, conducted when Cytokinetics was partnering the drug with Amgen, in which the drug met its primary objective of reducing cardiovascular death or heart failure events compared with placebo in HFrEF patients, cutting the combined rate by 8%. with omecamtiv mecarbil from 39.1%

Documentation 52

Documentation Labelling 52

GMPSOP

JUNE 28, 2024

Deviations are unusual or unexplained events that can potentially impact product quality, system integrity, or personal safety. Additional documents included each month. Packaging/labeling/Misbranding: 41 warnings vi. Similarly, the packaging, labeling, and misbranding-related warning letters were the top reasons in 2019.

Documentation 59

Documentation Packaging Labelling Pharmaceutical Manufacturing 59

GMPSOP

OCTOBER 28, 2023

The analyst should ensure that the supervisor is notified as soon as an OOS event occurs, the sample is retained, and a documented investigation is commenced. – Document control records management and archiving systems. Additional documents included each month. All written and updated by GMP experts.

Documentation 52

Documentation Method Validation Packaging Data Entry 52

Express Pharma

JUNE 2, 2023

By accurately documenting the movement of drugs, manufacturers can identify any quality issues that may arise during production, storage, or transportation. Quality control and regulatory compliance: Traceability is crucial for maintaining quality control and ensuring compliance with stringent regulations in the medicine space.

Adverse Reactions 89

Adverse Reactions Packaging Documentation Dosage 89

GMPSOP

FEBRUARY 25, 2023

Finished product samples are drowned from packed products to check if the labels are applied correctly, batch number and expiry dates are correct and legible. You will also check printed labels that are affixed on primary containers display correct information (e.g., Additional documents included each month.

Labelling 52

Labelling Packaging Documentation Pharmaceutical Manufacturing 52

GMPSOP

AUGUST 23, 2022

Assessing the impact of changes to a process/system The use of quality risk management and the methodology to be used should be documented in the relevant validation plan or change management procedure. Additional documents included each month. Assessing validation failures/deviations 4. All written and updated by GMP experts.

Documentation 52

Documentation Communication Pharmaceutical Manufacturing Labelling 52

FDA Law Blog: Biosimilars

FEBRUARY 28, 2024

On July 7, 2023, armed with these new procedures, CDER notified Oncopeptides that it proposed expedited withdrawal of Pepaxto because the postapproval study failed to verify clinical benefit and because Pepaxto was not shown to be safe or effective under its conditions of use (the documents discussed herein are published in the docket here ).

Documentation 57

Documentation Labelling Drug Development 57

GMPSOP

AUGUST 28, 2023

Raw materials must be inspected to confirm that the containers are intact, have been provided according to the paperwork, and have labels affixed on them identifying the raw material name, batch number, and expiry date. For example, materials with Hold, Quarantine, or Rejected labels must be kept in a quarantine location.

Health and Personal Care Stores 52

Health and Personal Care Stores Labelling Packaging Documentation 52

FDA Law Blog: Biosimilars

OCTOBER 10, 2023

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”

Documentation 44

Documentation Labelling Communication 44

Pharmaceutical Technology

OCTOBER 13, 2022

In July 2019, the MHRA held up Colonis for sending a letter to physicians advertising the off-label use of the drug in children and those with renal impairment. On 22 September, the MHRA expanded the label to include the use for sleep-onset insomnia in children with ADHD. No significant adverse events were reported.

Labelling 59

Labelling Dosage Documentation 59

RX Note

JUNE 4, 2023

Introduction Once, I received a query from a ward nurse: If a product label mentioned that "Do not store over 25°C", is it fine for us to keep the medication in fridge? What does a cool place on the product label mean? Read the label to know the recommended storage temperature range.

Drug Storage 52

Drug Storage Labelling Medication Labelling Documentation 52

FDA Law Blog: Biosimilars

MAY 8, 2023

a) , and related guidance documents (e.g., Post-market, manufacturers can make modifications consistent with the PCCP and document the modification in accordance with their quality system, without the need for a new marketing submission. See 21 CFR 807.81(a)(3) a)(3) and 21 CFR 814.39(a)

Documentation 98

Documentation Labelling 98

GMPSOP

MARCH 17, 2023

Additional documents included each month. – Status control: implementing status labels to clearly identify workflow status such as issues, returns, rejects and reworks of components to prevent mix ups. Additional documents included each month. Preventive action is taken to fix the cause of a problem before it can happen.

Documentation 52

Documentation Packaging Process Improvement Pharmaceutical Manufacturing 52

GMPSOP

MARCH 4, 2023

Quality risk management involves the art and science of identifying, analyzing, assessing, and managing uncertain events. Events that can impact product quality or compliance with registered dossier throughout a product’s life. Additional documents included each month. All written and updated by GMP experts.

Documentation 52

Documentation Communication Method Validation Packaging 52

Quality Matters

AUGUST 3, 2023

ampules, bottles, labels, cartons, shipping containers, desiccants) Services (e.g., This risk assessment effort is not a one-time event but rather a periodic, recurring process for communicating and reviewing risks,” noted USP’s Horacio Pappa, Ph.D., active ingredients, excipients, other raw materials) Packaging materials (e.g.,

Packaging 52

Packaging Compounding Pharmacies Pharmaceutical Manufacturing Documentation 52

FDA Law Blog: Biosimilars

JANUARY 1, 2024

Two device manufacturers received Warning Letters for QSR violations (QSR is FDA’s label for cGMP requirements applicable to medical device manufacturers). market complaints in 2021 through 2023 but could not provide documentation to demonstrate how the complaints were reviewed or evaluated. Terragene S.A., Terragene S.A., Shah, M.D.,

Documentation 57

Documentation Labelling 57

pharmaphorum

AUGUST 31, 2021

ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. Beyond the FDA, other institutions have documented what industry standards should look like in assessing RWD in a regulatory context. Furthermore, ECAs are well-documented in the post-approval setting.

Insurance Coverage and Processing 73

Insurance Coverage and Processing Drug Development Documentation Labelling 73

pharmaphorum

FEBRUARY 25, 2021

We attended the Rare Disease Day Virtual Parliamentary Event to find out. This enables rapid assessment and decision making for requests that fall outside commissioned services, including off-label treatment. How has rare disease care changed over the last few years? And what might we expect from the next five?

Documentation 97

Documentation Labelling 97

Pharmaceutical Technology

SEPTEMBER 7, 2022

AEs can be caused by using medicinal products within or outside the terms of their marketing authorisations (such as off-label therapeutic use, overdose, misuse, abuse or medication errors), as well as from occupational exposure.

Data Entry 52

Data Entry Vaccines Documentation Labelling 52

pharmaphorum

OCTOBER 4, 2022

The FDA explains that regardless of the complexity of the software and whether or not the software is proprietary, the output or labelling should provide HCP users with adequate background information in plain language on the input(s), algorithm logic or methods, datasets, and validation. Criteria for regulation.

Documentation 103

Documentation Labelling Communication 103

GMPSOP

JULY 31, 2023

These requirements mandate that pharmaceutical companies thoroughly document OQ protocols, testing methods, acceptance criteria, and results. Installation qualification verifies and documents that all critical aspects of equipment installation adhere to predetermined specifications and manufacturer’s recommendations.

Documentation 52

Documentation Dosage Labelling Data Entry 52

Putting Patients First Blog

JULY 2, 2024

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Off-label usage often emerges from real- world clinical practice and patient experiences, which might not be reflected in the guidelines.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing HIPAA Labelling 52

PharmD Live

FEBRUARY 17, 2022

Acute cardiac injury has been a well-documented feature of infection with SARS-CoV-2, which causes COVID-19 among patients requiring hospitalization. It is well understood that patients who experience acute cardiac events or chronic uncontrolled hypertension are at a significantly increased risk of developing heart failure, for example.

Hospitals 52

Hospitals Diabetes Documentation Labelling 52

pharmaphorum

SEPTEMBER 15, 2020

The external part of this is ensuring agility around adapting customer messages to meet the market needs with ‘quick-turn’ content updates that react to the events of today and tomorrow.”. The mindset that accomplished this needs to be retained,” Jeremy says.

Communication 118

Communication Documentation Labelling Vaccines 118

Viseven

NOVEMBER 17, 2022

They provide information about the following: Off-label usage Publications Safety information Independent medical education. As a result of these developments, companies are trying to manage contact centers and create accurate response documents effectively. What do medical affairs teams do? .

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 52

LifeProNow

APRIL 19, 2023

The primary endpoint evaluated in this study is progression-free survival, defined as time from randomization to the first documentation of progressive disease or death due to any cause, whichever occurs first. Monitor for neurologic events after treatment with ABECMA. and Europe.” Three cases of Grade 2 HLH/MAS resolved.

Adverse Reactions 100

Adverse Reactions Vaccines Immunity Immunization 100

LifeProNow

APRIL 9, 2023

These sNDAs are supported by results from the PHAROS trial ( NCT03915951 ), an open-label, multicenter, non-randomized, Phase 2 study (n=98) to determine the safety, tolerability, and efficacy of BRAFTOVI given in combination with MEKTOVI in patients with BRAF V600E-mutant metastatic NSCLC. of patients. of patients. of patients.

Adverse Reactions 100

Adverse Reactions Labelling Documentation 100

The Thyroid Pharmacist

JULY 29, 2022

But massive wildfire events like the ones in Colorado are both a cause and symptom of climate change. Perhaps more concerning, of the 133 different VOCs found across all tested products, only one, ethanol, was actually listed on any label! (13, For sunscreens and other over-the-counter drugs, fragrances must be identified on the label.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Immunity Immunization 52

The Thyroid Pharmacist

JULY 14, 2023

Individual doctors may still be able to utilize this therapy with their patients as an “off-label” use. For recipes, a FREE Thyroid Diet start guide, notifications about upcoming events, and the Nutrient Depletions and Digestion chapter from my first book for free, be sure to sign up for my email list ! References [1] Nanan R, Wall JR.

Dosage 98

Dosage Immunity Immunization Documentation 98

RX Note

FEBRUARY 23, 2023

G6PD Deficiency - Explaining G6PD Deficiency Ramadan - Medications during Ramadan fasting Adverse Drug Reactions Adverse Drug Reactions - All adverse reactions are adverse drug event Pharmacovigilance - To detect unreported ADRs Drug Allergy - Management vary based on the signs and symptoms Medicine-induced Discolouration - Red?

HIV Treatment and Prevention Agents 75

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 75

FDA Law Blog: Biosimilars

JULY 9, 2024

This could be based on differential pharmacokinetics (“PK”) or pharmacodynamics (“PD”), possible differences in susceptibility to specific adverse events of concern, or due to differential presentation of the disease or condition. Would any such failure to meet DAP goals be reflected in labeling?

Drug Development 57

Drug Development Communication Documentation Labelling 57

The Thyroid Pharmacist

NOVEMBER 8, 2024

Leaky gut has been documented in a number of autoimmune diseases (and we know it is considered a requirement in someone developing Hashimoto’s), including rheumatoid arthritis, inflammatory bowel disease, celiac disease, multiple sclerosis, ankylosing spondylitis, nonalcoholic steatohepatitis, and IgA nephropathy. [75]

Immunity 68

Immunity Immunization Diabetes Adverse Reactions 68